JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.101, sa.11, ss.3959-3967, 2016 (SCI-Expanded)
Background: In boys with suspected partial androgen insensitivity syndrome (PAIS), systematic evidence that supports the long-term prognostic value of identifying a mutation in the androgen receptor gene (AR) is lacking.